logo

ALGS

AligosยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

ALGS Profile

Aligos Therapeutics, Inc.

A clinical stage biopharmaceutical company that developing therapeutics for viral and liver diseases

Pharmaceutical
02/05/2018
10/16/2020
NASDAQ Stock Exchange
70
12-31
Common stock
One Corporate Drive, 2nd Floor, South San Francisco, California 94080
--
Aligos Therapeutics, Inc., was incorporated in Delaware on February 5, 2018. The company is a clinical-stage biopharmaceutical company focused on developing novel therapies to address unmet medical needs in liver disease and viral infections.